首页 | 本学科首页   官方微博 | 高级检索  
     


ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia
Authors:Gelareh Farshid  Michael Bilous  Adrienne Morey  Stephen Fox  Sunil Lakhani  Sherene Loi  Richard Bell  Andrew Spillane
Affiliation:1. SA Pathology, Royal Adelaide Hospital, Adelaide, SA, Australia;2. Western Sydney University, and Australian Clinical Labs, Sydney, NSW, Australia;3. ACT Pathology, Canberra Hospital, and ANU Medical School, Canberra, ACT, Australia;4. Department of Pathology, Peter MacCallum Cancer Centre, and the University of Melbourne, Melbourne, Vic, Australia;5. The University of Queensland Centre for Clinical Research, and Pathology Queensland Research, Brisbane, Qld, Australia;6. Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia;7. Medical Oncology, Deakin University, Vic, Australia;8. Surgical Oncology, The University of Sydney, and Mater Hospital North Sydney, Sydney, NSW, Australia
Abstract:
Keywords:HER2 immunohistochemistry  breast cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号